Bridges Investment Management Inc. Grows Stock Holdings in Chemed Co. (NYSE:CHE)

Bridges Investment Management Inc. raised its stake in shares of Chemed Co. (NYSE:CHE) by 3.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,229 shares of the company’s stock after purchasing an additional 2,149 shares during the quarter. Bridges Investment Management Inc. owned approximately 0.48% of Chemed worth $43,407,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of CHE. Thrivent Financial for Lutherans boosted its position in shares of Chemed by 300.3% during the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock valued at $63,249,000 after purchasing an additional 87,449 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Chemed in the 3rd quarter worth about $437,150,000. Impax Asset Management Group plc lifted its position in Chemed by 19.5% during the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock valued at $172,510,000 after acquiring an additional 51,974 shares during the period. ProShare Advisors LLC boosted its stake in Chemed by 6,288.9% during the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after acquiring an additional 49,808 shares in the last quarter. Finally, TD Asset Management Inc grew its holdings in Chemed by 23.9% in the first quarter. TD Asset Management Inc now owns 254,953 shares of the company’s stock worth $163,662,000 after purchasing an additional 49,176 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday.

Chemed Price Performance

Shares of Chemed stock opened at $559.06 on Friday. The stock has a market cap of $8.41 billion, a price-to-earnings ratio of 28.25, a PEG ratio of 2.23 and a beta of 0.46. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62. The firm’s 50-day moving average is $582.20 and its 200 day moving average is $566.23.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same quarter in the prior year, the company posted $5.32 EPS. The company’s quarterly revenue was up 7.4% on a year-over-year basis. On average, equities analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Insider Transactions at Chemed

In other Chemed news, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the transaction, the director now owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Chemed news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director George J. Walsh III sold 200 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the sale, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,144 shares of company stock worth $3,002,419 over the last quarter. 3.32% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.